159 related articles for article (PubMed ID: 35046521)
1. Urine DNA biomarkers for hepatocellular carcinoma screening.
Kim AK; Hamilton JP; Lin SY; Chang TT; Hann HW; Hu CT; Lou Y; Lin YJ; Gade TP; Park G; Luu H; Lee TJ; Wang J; Chen D; Goggins MG; Jain S; Song W; Su YH
Br J Cancer; 2022 Jun; 126(10):1432-1438. PubMed ID: 35046521
[TBL] [Abstract][Full Text] [Related]
2. Novel urine cell-free DNA methylation markers for hepatocellular carcinoma.
Lin SY; Xia W; Kim AK; Chen D; Schleyer S; Choi L; Wang Z; Hamilton JP; Luu H; Hann HW; Chang TT; Hu CT; Woodard A; Gade TP; Su YH
Sci Rep; 2023 Dec; 13(1):21585. PubMed ID: 38062093
[TBL] [Abstract][Full Text] [Related]
3. A Novel Blood-Based Panel of Methylated DNA and Protein Markers for Detection of Early-Stage Hepatocellular Carcinoma.
Chalasani NP; Ramasubramanian TS; Bhattacharya A; Olson MC; Edwards V DK; Roberts LR; Kisiel JB; Reddy KR; Lidgard GP; Johnson SC; Bruinsma JJ
Clin Gastroenterol Hepatol; 2021 Dec; 19(12):2597-2605.e4. PubMed ID: 32889146
[TBL] [Abstract][Full Text] [Related]
4. Tumor-associated autoantibodies in combination with alpha-fetoprotein for detection of early stage hepatocellular carcinoma.
Welberry C; Macdonald I; McElveen J; Parsy-Kowalska C; Allen J; Healey G; Irving W; Murray A; Chapman C
PLoS One; 2020; 15(5):e0232247. PubMed ID: 32374744
[TBL] [Abstract][Full Text] [Related]
5. Abdominal ultrasound and alpha-foetoprotein for the diagnosis of hepatocellular carcinoma in adults with chronic liver disease.
Colli A; Nadarevic T; Miletic D; Giljaca V; Fraquelli M; Štimac D; Casazza G
Cochrane Database Syst Rev; 2021 Apr; 4(4):CD013346. PubMed ID: 33855699
[TBL] [Abstract][Full Text] [Related]
6. Combination of miR-125b and miR-27a enhances sensitivity and specificity of AFP-based diagnosis of hepatocellular carcinoma.
Zuo D; Chen L; Liu X; Wang X; Xi Q; Luo Y; Zhang N; Guo H
Tumour Biol; 2016 May; 37(5):6539-49. PubMed ID: 26637228
[TBL] [Abstract][Full Text] [Related]
7. Identification of mutations in circulating cell-free tumour DNA as a biomarker in hepatocellular carcinoma.
Howell J; Atkinson SR; Pinato DJ; Knapp S; Ward C; Minisini R; Burlone ME; Leutner M; Pirisi M; Büttner R; Khan SA; Thursz M; Odenthal M; Sharma R
Eur J Cancer; 2019 Jul; 116():56-66. PubMed ID: 31173963
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive evaluation of microRNA as a biomarker for the diagnosis of hepatocellular carcinoma.
Malik J; Klammer M; Rolny V; Chan HL; Piratvisuth T; Tanwandee T; Thongsawat S; Sukeepaisarnjaroen W; Esteban JI; Bes M; Köhler B; Swiatek-de Lange M
World J Gastroenterol; 2022 Aug; 28(29):3917-3933. PubMed ID: 36157551
[TBL] [Abstract][Full Text] [Related]
9. Using circulating tumor DNA as a novel biomarker to screen and diagnose hepatocellular carcinoma: A systematic review and meta-analysis.
Zhang Z; Chen P; Xie H; Cao P
Cancer Med; 2020 Feb; 9(4):1349-1364. PubMed ID: 31876977
[TBL] [Abstract][Full Text] [Related]
10. The GALAD scoring algorithm based on AFP, AFP-L3, and DCP significantly improves detection of BCLC early stage hepatocellular carcinoma.
Best J; Bilgi H; Heider D; Schotten C; Manka P; Bedreli S; Gorray M; Ertle J; van Grunsven LA; Dechêne A
Z Gastroenterol; 2016 Dec; 54(12):1296-1305. PubMed ID: 27936479
[No Abstract] [Full Text] [Related]
11. Diagnostic value of AFP-L3 and PIVKA-II in hepatocellular carcinoma according to total-AFP.
Choi JY; Jung SW; Kim HY; Kim M; Kim Y; Kim DG; Oh EJ
World J Gastroenterol; 2013 Jan; 19(3):339-46. PubMed ID: 23372355
[TBL] [Abstract][Full Text] [Related]
12. Cell-free methylation markers with diagnostic and prognostic potential in hepatocellular carcinoma.
Lu CY; Chen SY; Peng HL; Kan PY; Chang WC; Yen CJ
Oncotarget; 2017 Jan; 8(4):6406-6418. PubMed ID: 28031532
[TBL] [Abstract][Full Text] [Related]
13. The Diagnostic Value of Serum PIVKA-II Alone or in Combination with AFP in Chinese Hepatocellular Carcinoma Patients.
Xu F; Zhang L; He W; Song D; Ji X; Shao J
Dis Markers; 2021; 2021():8868370. PubMed ID: 33628341
[TBL] [Abstract][Full Text] [Related]
14. DNA methylation markers and serum α-fetoprotein level are prognostic factors in hepatocellular carcinoma.
Lin JC; Wu YC; Wu CC; Shih PY; Wang WY; Chien YC
Ann Hepatol; 2015; 14(4):494-504. PubMed ID: 26019036
[TBL] [Abstract][Full Text] [Related]
15. RASSF1A and SOCS1 genes methylation status as a noninvasive marker for hepatocellular carcinoma.
Pasha HF; Mohamed RH; Radwan MI
Cancer Biomark; 2019; 24(2):241-247. PubMed ID: 30689554
[TBL] [Abstract][Full Text] [Related]
16. Circulating DNA methylation profile improves the accuracy of serum biomarkers for the detection of nonmetastatic hepatocellular carcinoma.
Phan TH; Chi Nguyen VT; Thi Pham TT; Nguyen VC; Ho TD; Quynh Pham TM; Tran TH; Nguyen TD; Khang Le ND; Nguyen TH; Duong ML; Bach HT; Kim VV; Pham TA; Nguyen BT; Vo Nguyen TN; Nguyen TD; Bieu Phu DT; Huu Phan BH; Nguyen DS; Truong DK; Do TT; Giang H; Nguyen HN; Phan MD; Tran LS
Future Oncol; 2022 Dec; 18(39):4399-4413. PubMed ID: 36786635
[TBL] [Abstract][Full Text] [Related]
17. Application of classification tree and neural network algorithms to the identification of serological liver marker profiles for the diagnosis of hepatocellular carcinoma.
Poon TC; Chan AT; Zee B; Ho SK; Mok TS; Leung TW; Johnson PJ
Oncology; 2001; 61(4):275-83. PubMed ID: 11721174
[TBL] [Abstract][Full Text] [Related]
18. Hepatocellular Carcinoma Screening Utilising Serum Alpha-Fetoprotein Measurement and Abdominal Ultrasound Is More Effective than Ultrasound Alone in Patients with Non-viral Cirrhosis.
Worland T; Harrison B; Delmenico L; Dowling D
J Gastrointest Cancer; 2018 Dec; 49(4):476-480. PubMed ID: 28920172
[TBL] [Abstract][Full Text] [Related]
19. Serum miR-224 as a biomarker for detection of hepatocellular carcinoma at early stage.
Lin L; Lu B; Yu J; Liu W; Zhou A
Clin Res Hepatol Gastroenterol; 2016 Sep; 40(4):397-404. PubMed ID: 26724963
[TBL] [Abstract][Full Text] [Related]
20. HepaClear, a blood-based panel combining novel methylated CpG sites and protein markers, for the detection of early-stage hepatocellular carcinoma.
Bai Y; Xu J; Li D; Zhang X; Chen D; Xie F; Huang L; Yu X; Zhao H; Zhang Y
Clin Epigenetics; 2023 Jun; 15(1):99. PubMed ID: 37308980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
